BROADWOOD CAPITAL INC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001278387

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedConsumer TiltBuy & Hold how tags are computed

Q2 2026 · 6 positions · Total reported value $1.91B · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +33.5% · vs SPY +18.6% · Prev Value $1.42B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, BROADWOOD CAPITAL INC disclosed 6 equity positions with a combined reported value of $1.91B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were MNST ($779.32M), STAA ($462.59M), AXON ($388.79M). By sector, the heaviest allocations are Consumer Staples 40.7%, Health Care 31.5%. Versus the prior quarter, allocation shifted toward Health Care (+2.0pp) and away from Consumer Staples (-0.7pp), Other (-0.8pp).

Versus the prior quarter, BROADWOOD CAPITAL INC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest BROADWOOD CAPITAL INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-04-27 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-27 Buy Insight Molecular Diagnostics Inc. 250,923 $3.64 SEC filing
2026-04-24 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-24 Buy Insight Molecular Diagnostics Inc. 38,880 $3.53 SEC filing
2026-04-23 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-23 Buy Insight Molecular Diagnostics Inc. 280,381 $3.50 SEC filing
2026-04-20 Buy Insight Molecular Diagnostics Inc. — — SEC filing
2026-04-20 Buy Insight Molecular Diagnostics Inc. 40,690 $3.88 SEC filing

All insider transactions →

Fund Profile

Broadwood Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 6 US equity positions with a combined value of $1.91B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73853 (status: Approved), registered 2012-03-27
  • Regulatory AUM (Form ADV): $1.71B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: broadwoodcapital.com

Portfolio Structure

  • 6 positions · $1.91B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MNST (MONSTER BEVERAGE CORP NEW) at 40.7%
  • Average position size: $318.86M

Sector Tilt

  • Consumer Staples 40.7%
  • Health Care 31.5%
  • Industrials 20.3%
  • (classified holdings cover 93% of value)

Quarterly Activity

  • Q2 2026: 1 added
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The BROADWOOD CAPITAL INC fund maintained a conservative stance during the 2026-Q2 quarter, with a slight increase in healthcare sector exposure. The lack of additions and significant changes to positions suggests a cautious approach amidst market uncertainty. 2. Key Moves: - Added: Insight Molecular Diagnostics (IMDX) was added to the portfolio with a 6.3% increase in shares, reflecting an interest in the healthcare sector. - No Change: The fund held its positions steady in MNST, STAA, AXON, IWM, and LCTX, with no changes in share count or weight. - No Reductions: There were no reported reductions in any holdings. 3. Portfolio Structure: - Passive/Active: The fund appears to be more passive in nature, with a focus on holding onto existing positions and slight adjustments. - Sector Bias: The portfolio is biased towards healthcare, with two significant holdings in the sector. - Risk Appetite: The fund shows a moderate risk appetite, with a conservative approach to rebalancing and minimal changes to the portfolio. 4. Per-Holding One-Liner: - MNST (MONSTER BEVERAGE CORP NEW): Manufacturer of non-alcoholic beverages. - STAA (STAAR SURGICAL CO): Manufacturer of ophthalmic surgical devices. - AXON (AXON ENTERPRISE INC): Provides cloud infrastructure services. - IWM (ISHARES TR): Tracking the Russell 1000 Index, representing large-cap U.S. stocks. - IMDX (INSIGHT MOLECULAR DIAGNO): Offers diagnostic solutions for genetic testing. - LCTX (LINEAGE CELL THERAPEUTICS IN): Biotechnology company focused on cellular therapies. 5. One-Sentence Style Summary: The BROADWOOD CAPITAL INC fund maintained a conservative investment strategy in Q2 2026, focusing on stability and slight expansion in healthcare exposure.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 31.5%
Industrials 20.3%
Other 7.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.11M $779.32M 40.73%
40.73%
Hold
2 16.12M $462.59M 24.18%
24.18%
Hold
3 693.50K $388.79M 20.32%
20.32%
Hold
4 474.92K $142.69M 7.46%
7.46%
Hold
5 12.68M $74.84M 3.91%
3.91%
Add
6 49.56M $64.92M 3.39%
3.39%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 100% R 100% F1 100% (modelled on 2026-Q1; 6/10 hit)

Historical Backtest (10 quarters)

Avg precision 90% · recall 91% · F1 90% · avg rank error 0.8 · Top-10 turnover 8%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 86% 86% 86% MNST · STAA · AXON · IWM · LCTX · IMDX · AGE MNST · STAA · AXON · IWM · LCTX · IMDX · SER
2024-Q2 100% 100% 100% MNST · STAA · AXON · IWM · LCTX · IMDX · SER STAA · MNST · AXON · IWM · LCTX · IMDX · SER
2024-Q3 100% 100% 100% STAA · MNST · AXON · IWM · LCTX · IMDX · SER MNST · STAA · AXON · IWM · LCTX · IMDX · SER
2024-Q4 100% 100% 100% MNST · STAA · AXON · IWM · LCTX · IMDX · SER MNST · AXON · STAA · IWM · LCTX · IMDX · SER
2025-Q1 100% 88% 93% MNST · AXON · STAA · IWM · LCTX · IMDX · SER MNST · AXON · STAA · IWM · IMDX · LCTX · OLO · SER
2025-Q2 88% 70% 78% MNST · AXON · STAA · IWM · IMDX · LCTX · OLO · SER AXON · MNST · STAA · IWM · LCTX · IMDX · OLO · UAL · AAL · LUV
2025-Q3 90% 90% 90% AXON · MNST · STAA · IWM · LCTX · OLO · IMDX · UAL · AAL · LUV MNST · AXON · STAA · IWM · LCTX · IMDX · UAL · HBI · LUV · AAL
2025-Q4 80% 80% 80% MNST · AXON · STAA · IWM · LCTX · IMDX · UAL · HBI · DAL · LUV MNST · AXON · STAA · IWM · IMDX · LCTX · UAL · AAL · LUV · GIL
2026-Q1 60% 100% 75% MNST · AXON · STAA · IWM · IMDX · LCTX · UAL · AAL · LUV · GIL MNST · STAA · AXON · IWM · LCTX · IMDX
2026-Q2 ★ 100% 100% 100% MNST · STAA · AXON · IWM · LCTX · IMDX MNST · STAA · AXON · IWM · IMDX · LCTX

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did BROADWOOD CAPITAL INC buy in 2026-Q2?

In its 2026-Q2 13F filing, BROADWOOD CAPITAL INC reported 6 equity positions worth $1.91B in aggregate; its largest disclosed positions were MNST ($779.32M), STAA ($462.59M), AXON ($388.79M).

How large is BROADWOOD CAPITAL INC's portfolio?

BROADWOOD CAPITAL INC reported $1.91B of long equity holdings across 6 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is BROADWOOD CAPITAL INC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/broadwood-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →